vs

Side-by-side financial comparison of INTERNATIONAL BANCSHARES CORP (IBOC) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

UNIVERSAL TECHNICAL INSTITUTE INC is the larger business by last-quarter revenue ($220.8M vs $217.7M, roughly 1.0× INTERNATIONAL BANCSHARES CORP). INTERNATIONAL BANCSHARES CORP runs the higher net margin — 62.3% vs 5.8%, a 56.5% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (9.6% vs 4.5%). INTERNATIONAL BANCSHARES CORP produced more free cash flow last quarter ($472.9M vs $-19.2M). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (9.5% CAGR vs 2.8%).

International Bancshares Corporation is a bank holding company based in Laredo, Texas whose primary subsidiary is International Bank of Commerce. Through its bank subsidiaries, it has 217 banking offices and 315 automated teller machines serving 88 communities in the U.S. states of Texas and Oklahoma.

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

IBOC vs UTI — Head-to-Head

Bigger by revenue
UTI
UTI
1.0× larger
UTI
$220.8M
$217.7M
IBOC
Growing faster (revenue YoY)
UTI
UTI
+5.1% gap
UTI
9.6%
4.5%
IBOC
Higher net margin
IBOC
IBOC
56.5% more per $
IBOC
62.3%
5.8%
UTI
More free cash flow
IBOC
IBOC
$492.1M more FCF
IBOC
$472.9M
$-19.2M
UTI
Faster 2-yr revenue CAGR
UTI
UTI
Annualised
UTI
9.5%
2.8%
IBOC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IBOC
IBOC
UTI
UTI
Revenue
$217.7M
$220.8M
Net Profit
$106.9M
$12.8M
Gross Margin
Operating Margin
62.8%
7.1%
Net Margin
62.3%
5.8%
Revenue YoY
4.5%
9.6%
Net Profit YoY
-7.1%
-42.1%
EPS (diluted)
$1.71
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IBOC
IBOC
UTI
UTI
Q4 25
$217.7M
$220.8M
Q3 25
$218.1M
$222.4M
Q2 25
$208.2M
$204.3M
Q1 25
$198.2M
$207.4M
Q4 24
$208.3M
$201.4M
Q3 24
$211.8M
$196.4M
Q2 24
$207.8M
$177.5M
Q1 24
$205.8M
$184.2M
Net Profit
IBOC
IBOC
UTI
UTI
Q4 25
$106.9M
$12.8M
Q3 25
$108.4M
$18.8M
Q2 25
$100.1M
$10.7M
Q1 25
$96.9M
$11.4M
Q4 24
$115.1M
$22.2M
Q3 24
$99.8M
$18.8M
Q2 24
$97.0M
$5.0M
Q1 24
$97.3M
$7.8M
Operating Margin
IBOC
IBOC
UTI
UTI
Q4 25
62.8%
7.1%
Q3 25
62.6%
11.2%
Q2 25
60.5%
6.9%
Q1 25
61.1%
8.1%
Q4 24
64.2%
13.6%
Q3 24
60.0%
13.3%
Q2 24
60.1%
4.2%
Q1 24
59.9%
6.1%
Net Margin
IBOC
IBOC
UTI
UTI
Q4 25
62.3%
5.8%
Q3 25
49.7%
8.4%
Q2 25
48.1%
5.2%
Q1 25
48.9%
5.5%
Q4 24
71.5%
11.0%
Q3 24
47.1%
9.6%
Q2 24
46.7%
2.8%
Q1 24
47.3%
4.2%
EPS (diluted)
IBOC
IBOC
UTI
UTI
Q4 25
$1.71
$0.23
Q3 25
$1.74
$0.33
Q2 25
$1.61
$0.19
Q1 25
$1.56
$0.21
Q4 24
$1.85
$0.40
Q3 24
$1.60
$0.35
Q2 24
$1.56
$0.09
Q1 24
$1.56
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IBOC
IBOC
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$5.5B
$162.8M
Total DebtLower is stronger
$101.4M
Stockholders' EquityBook value
$3.3B
$335.9M
Total Assets
$16.6B
$834.0M
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IBOC
IBOC
UTI
UTI
Q4 25
$5.5B
$162.8M
Q3 25
$5.6B
$169.1M
Q2 25
$5.8B
$70.7M
Q1 25
$5.6B
$96.0M
Q4 24
$5.4B
$172.0M
Q3 24
$5.8B
$161.9M
Q2 24
$5.7B
$115.5M
Q1 24
$5.7B
$116.1M
Total Debt
IBOC
IBOC
UTI
UTI
Q4 25
$101.4M
Q3 25
$87.1M
Q2 25
$73.8M
Q1 25
$94.4M
Q4 24
$120.1M
Q3 24
$125.7M
Q2 24
$137.3M
Q1 24
$141.9M
Stockholders' Equity
IBOC
IBOC
UTI
UTI
Q4 25
$3.3B
$335.9M
Q3 25
$3.1B
$328.1M
Q2 25
$3.0B
$306.8M
Q1 25
$2.9B
$293.9M
Q4 24
$2.8B
$280.0M
Q3 24
$2.7B
$260.2M
Q2 24
$2.6B
$239.4M
Q1 24
$2.5B
$232.6M
Total Assets
IBOC
IBOC
UTI
UTI
Q4 25
$16.6B
$834.0M
Q3 25
$16.6B
$826.1M
Q2 25
$16.5B
$740.8M
Q1 25
$16.3B
$720.4M
Q4 24
$15.7B
$753.8M
Q3 24
$15.9B
$744.6M
Q2 24
$15.5B
$706.0M
Q1 24
$15.4B
$702.1M
Debt / Equity
IBOC
IBOC
UTI
UTI
Q4 25
0.30×
Q3 25
0.27×
Q2 25
0.24×
Q1 25
0.32×
Q4 24
0.43×
Q3 24
0.48×
Q2 24
0.57×
Q1 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IBOC
IBOC
UTI
UTI
Operating Cash FlowLast quarter
$491.1M
$3.1M
Free Cash FlowOCF − Capex
$472.9M
$-19.2M
FCF MarginFCF / Revenue
217.2%
-8.7%
Capex IntensityCapex / Revenue
8.3%
10.1%
Cash ConversionOCF / Net Profit
4.59×
0.24×
TTM Free Cash FlowTrailing 4 quarters
$809.9M
$16.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IBOC
IBOC
UTI
UTI
Q4 25
$491.1M
$3.1M
Q3 25
$115.2M
$57.1M
Q2 25
$95.5M
$18.1M
Q1 25
$140.5M
$-789.0K
Q4 24
$473.9M
$23.0M
Q3 24
$116.5M
$67.5M
Q2 24
$107.2M
$10.0M
Q1 24
$135.4M
$-2.5M
Free Cash Flow
IBOC
IBOC
UTI
UTI
Q4 25
$472.9M
$-19.2M
Q3 25
$112.2M
$40.6M
Q2 25
$91.6M
$6.8M
Q1 25
$133.1M
$-11.7M
Q4 24
$459.8M
$19.6M
Q3 24
$109.6M
$60.0M
Q2 24
$104.9M
$3.0M
Q1 24
$128.9M
$-8.4M
FCF Margin
IBOC
IBOC
UTI
UTI
Q4 25
217.2%
-8.7%
Q3 25
51.5%
18.3%
Q2 25
44.0%
3.4%
Q1 25
67.1%
-5.7%
Q4 24
220.8%
9.7%
Q3 24
51.7%
30.6%
Q2 24
50.5%
1.7%
Q1 24
62.6%
-4.6%
Capex Intensity
IBOC
IBOC
UTI
UTI
Q4 25
8.3%
10.1%
Q3 25
1.3%
7.4%
Q2 25
1.9%
5.5%
Q1 25
3.7%
5.3%
Q4 24
6.8%
1.7%
Q3 24
3.3%
3.8%
Q2 24
1.1%
4.0%
Q1 24
3.2%
3.2%
Cash Conversion
IBOC
IBOC
UTI
UTI
Q4 25
4.59×
0.24×
Q3 25
1.06×
3.04×
Q2 25
0.95×
1.69×
Q1 25
1.45×
-0.07×
Q4 24
4.12×
1.04×
Q3 24
1.17×
3.58×
Q2 24
1.11×
2.01×
Q1 24
1.39×
-0.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IBOC
IBOC

Segment breakdown not available.

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

Related Comparisons